Improving access to genetic testing and counseling for the more than 30 million Americans who are living with a rare disease could improve research and ultimately patient outcomes, according to a ...

LA CROSSE (WKBT) - When it comes to your health, family history can play a huge role. That's why Mayo Clinic Health System experts recommend genetic testing. Testing can reveal mutations in your genes ...

Existing screening protocols in place are failing to identify patients who might be carriers of a genetic mutation that is linked to certain cancers, according to Mayo Clinic researchers. Both ...

DEAR MAYO CLINIC: My grandmother and mother, as well as an aunt and a cousin, have had breast cancer. Another cousin was diagnosed with colon cancer recently. It has been suggested that I undergo ...

A new genetic test developed at Mayo Clinic is redefining how clinicians diagnose and manage hereditary pancreatitis.

I've heard that ovarian cancer is hard to detect. Can you tell me more about the symptoms and if there are any screenings?

EAU CLAIRE, Wis. (WEAU) - World Cancer Day is Feb. 4. Health experts with Mayo Clinic Health System say it’s important to know if you’re at risk for cancer, which includes knowing your family history.

A Mayo Clinic-led team of researchers is solving one of the most frustrating aspects of genetic cancer screening — results that give zero guidance to patients on whether they are at elevated risk.

ROCHESTER, Minn. ¾ A Mayo Clinic study published in Journal of Translational Medicine evaluated the use of genomic testing broadly for rare diseases. With the increased use of genomic testing such as ...

DEAR MAYO CLINIC: My grandmother and mother, as well as an aunt and a cousin, have had breast cancer. Another cousin was diagnosed with colon cancer recently. It has been suggested that I undergo ...

PHOENIX — Current screening protocols fail to catch a notable number of people carrying genetic mutations associated with hereditary breast and ovarian cancer syndrome and Lynch syndrome, which ...

Mayo Clinic announced Monday that it is licensing a genotyping test for warfarin sensitivity in clinical and research settings from Ithaca, New York-based Rheonix Inc. Warfarin is an anticoagulant and ...